Immunomodulation of murine leishmaniasis with cyclosporin A.
Immunomodulation of murine leishmaniasis with cyclosporin A.
复制标题
用环孢菌素 A 对小鼠利什曼病进行免疫调节。
DOI:
10.1007/978-1-4757-5421-6_36
复制
发表时间:
1988
影响因子:
--
通讯作者:
Wenger,CD
中科院分区:
文献类型:
--
作者:
Behforouz,NC;Wenger,CD
The fungal metabolite, cyclosporin A (CsA), is an undecapeptide with novel immunosuppressive effects as well as anti-parasitic and antiinflammatory properties (1,2). CsA is particularly effective in preventing activation of T helper and T cytotoxic cells at the induction phase of T cell responses bothin vitroandin vivo(3). Although the mode of action of CsA is not yet entirely clear, it has been shown to inhibit the production of IL-2 and may have effects on other lymphoid communication signals and responsiveness (2–4). Cyclosporin A has been shown to have unexpected beneficial effects on certain parasitic infections in animal models of human disease. In murine malaria, cyclosporin A exhibited potent activity againstP. yoeliiandP. bergheiwhen administered to mice either prophylactically or therapeutically (5,6). Furthermore, CsA also markedly inhibited the growth ofPlasmodium falciparumin cultured human erythrocytes (6). In this work, both the therapeutic and prophylactic effects of the drug were thought to be due to the direct effect of the CsA on thePlasmodiumparasites. Surprisingly, CsA also had protective effects in mice infected with the helminthSchistosoma mansoni. Animals were protected both from primary infections and secondary challenges (7,8). In these studies, however, no direct effect of the drug on the parasite was observed, and it was concluded that the drug evoked a stimulation of host mechanisms directed against the parasite (8). In contrast to these studies, CsA treatment ofTrypanosoma cruziinfected mice was found to exacerbate the disease (9).